Among the 35 hub genes corresponding to the prognosis-related DNA methylation sites, the gene expression levels of DOK2, GBP4, PSMB9, and NLRC5 were significantly changed in different patient subgroups according to DNA methylation subtypes, patient states, tumor stages, and T categories. The gene discussed is PSMB9; the disease is neoplasm.